Archive

Weekly Round UpWeekly Round Up
From Line Item to National Imperative: The $36B Trauma Bet

From Line Item to National Imperative: The $36B Trauma Bet

Trauma care is no longer just an emergency response—it’s a growth sector projected to nearly double by 2034.

Research Deep DiveResearch Deep Dive
Critical Condition, Critical Capital: Trauma Centers Enter a Growth Era

Critical Condition, Critical Capital: Trauma Centers Enter a Growth Era

In an age of increasingly specialized care, trauma centers are emerging as one of the fastest-growing—and most strategically vital—segments of the healthcare infrastructure.

Weekly Round UpWeekly Round Up
GenAI Hits Healthcare: Innovation or Regulation Roadblock?

GenAI Hits Healthcare: Innovation or Regulation Roadblock?

Generative AI is no longer just hype—it’s entering clinics, hospitals, and care networks with unprecedented speed.

Research Deep DiveResearch Deep Dive
Generative AI in Healthcare: Promise Meets the Push for Regulation

Generative AI in Healthcare: Promise Meets the Push for Regulation

Generative AI is no longer a future vision—it is actively reshaping how healthcare is delivered, from diagnosis and drug discovery to administrative efficiency.

Weekly Round UpWeekly Round Up
Blockchain’s $193B Bet on Healthcare | Hear From Jon Ledecky, Bobby Sharma, Julia Wittlin, Ben Fund & More

Blockchain’s $193B Bet on Healthcare | Hear From Jon Ledecky, Bobby Sharma, Julia Wittlin, Ben Fund & More

The blockchain healthcare market is set to explode from $9.6B in 2024 to $193B by 2034.

Research Deep DiveResearch Deep Dive
Blockchain in Healthcare

Blockchain in Healthcare

From innovation to infrastructure: blockchain’s role in the future of healthcare

Weekly Round UpWeekly Round Up
2025: Healthcare’s Great Separation: What Every Executive Needs to Know

2025: Healthcare’s Great Separation: What Every Executive Needs to Know

Signal over noise: H2 favors platform scale, disciplined buyers, and the $4.91T biotech tailwind.

Research Deep DiveResearch Deep Dive
2025 Mid-Year Review

2025 Mid-Year Review

Six months into 2025, healthcare’s trajectory is defined not by uniform growth, but by divergence.

Weekly Round UpWeekly Round Up
Supply Problem, PE Solution: The Rural Health Platform Play

Supply Problem, PE Solution: The Rural Health Platform Play

Convert supply constraints into scale—MA roll-ups, tele-specialty networks, and mobile clinics where policy tailwinds meet unmet demand.

Research Deep DiveResearch Deep Dive
The Rural Health Paradox

The Rural Health Paradox

In the U.S., access to health insurance remains a defining challenge, and the disparity in coverage is particularly stark between urban and rural areas.

Weekly Round UpWeekly Round Up
KKR’s Bold Biopharma Play | Europe’s Hidden Healthcare Risk | AI’s Global Imbalance

KKR’s Bold Biopharma Play | Europe’s Hidden Healthcare Risk | AI’s Global Imbalance

Biopharmaceutical industry is expected to hit $1.8 trillion by 2034, North America still dominates half of the world in AI applications to healthcare.

Research Deep DiveResearch Deep Dive
Biopharmaceuticals: Entering a New Growth Era

Biopharmaceuticals: Entering a New Growth Era

Where Precision Meets Momentum.

Francisco Calle
Francisco Calle
FirstBack
123456
Next Last